VB
Virax Biolabs Group Limited Ordinary Shares
🇺🇸XNAS.VRAXUnited StatesHealthcare
$2.59USDunchanged 0.00 (0%)OpenDelayed3:26 PM
Price$2.590.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- KYG9495L1335
- CUSIP
- Not reported
Company
- Employees
- 26
- Headquarters
- Lanarkshire, United States
- Website
- https://viraxbiolabs.com
- CEO
- Mr. James Foster
Market
- Shares outstanding
- 797K
- Market cap
- $2.06M
Key dates
- Next earnings
- Oct 1, 2026
Highlights
No high and low reported for today's session.
- Market cap
- $2.06M
- EPS LTM
- -$170.86
- P/E LTM
- -0.04
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- -$81.5K-100%down year on year
- Net income
- -$10.63M-714.28%down year on year
- Gross margin
- 240.06%
- Free cash flow
- -$6.95M-795.6%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.